<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03605472</url>
  </required_header>
  <id_info>
    <org_study_id>PA17094</org_study_id>
    <nct_id>NCT03605472</nct_id>
  </id_info>
  <brief_title>Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism</brief_title>
  <acronym>ECHOPARAT</acronym>
  <official_title>Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biological diagnosis of the primary hyperparathyroidism is now facilitated by the
      reliability of the balance of phosphate and calcium and the dosage of parathyroid hormone
      (PTH).

      This diagnosis of preoperative localization is important as surgery are now targeted to the
      responsible lesion.

      The &quot;gold standard&quot; for this localization is the cervical ultrasound exploring the usual
      sites of adenomas and a MIBI scintigraphy (the parathyroid adenoma significantly
      concentrating this cell marker).

      However, the diagnosis of preoperative localization remains a subject of discussion as to the
      most appropriate tests. Indeed, the morphological diagnosis is performed at the ultrasound
      stage in more than half the cases. It is the new performance of this morphological
      examination that makes it possible to obtain these results.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">October 5, 2017</start_date>
  <completion_date type="Anticipated">March 5, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma parathyroid diagnosed using cervical ultrasound</measure>
    <time_frame>Day 0</time_frame>
    <description>Adenoma parathyroid diagnosed using cervical ultrasound. Cervical ultrasound will be realized by a endocrinologist trained in the cervical ultrasound and not informed of the results of the echoscintigraphy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adenoma parathyroid diagnosed using echoscintigraphy</measure>
    <time_frame>Day 0</time_frame>
    <description>Adenoma parathyroid diagnosed using echoscintigraphy. Echoscintigraphy will be realized by a nuclear physician not informed of the results of the cervical ultrasound</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adenoma parathyroid diagnosed using anatomopathology</measure>
    <time_frame>Day 0</time_frame>
    <description>Adenoma parathyroid diagnosed by anatomopathologist, after surgery.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Primary Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cervical ultrasound</intervention_name>
    <description>cervical ultrasound will be realized by a endocinologist trained in the cervical ultrasound</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with primary hyperparathyroidism with surgery indication

          -  Age &gt; 18yo

        Exclusion Criteria:

          -  surgical contraindication

          -  medical treatment by cinacalcet

          -  non sporadic hyperparathyroidism

          -  Age &lt;18yo

          -  Protected by the law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brigitte DELEMER</last_name>
    <phone>0326788101</phone>
    <email>bdelemer@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte DELEMER</last_name>
      <phone>0326788101</phone>
      <phone_ext>0033</phone_ext>
      <email>bdelemer@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2018</study_first_posted>
  <last_update_submitted>July 20, 2018</last_update_submitted>
  <last_update_submitted_qc>July 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary hyperparathyroidism</keyword>
  <keyword>cervical ultrasound</keyword>
  <keyword>echoscintigraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hyperparathyroidism, Primary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

